FDA Allows Claims Linking Calcium with Hypertension, Colon/Rectal Cancer
This article was originally published in The Tan Sheet
FDA will allow qualified health claims linking supplemental calcium intake to a decreased risk of hypertension, the agency announces Oct. 12
You may also be interested in...
Calcium supplementation has a protective effect on risk of colorectal adenoma recurrence for up to five years after subjects stopped taking calcium, according to a study published in the Journal of the National Cancer Institute Jan. 17
FDA should modify approved qualified health claims for the link between green tea and certain cancers, according to a petition from green tea marketer Fleminger
Coral calcium producer Marine Bio USA is requesting FDA approval of health claims linking calcium with a reduced risk of several diseases including cancers, hypertension and menstrual disorders